Human <scp>EGFRvIII</scp> chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma
MLA
Rebecca C Abbott, et al. “Human EGFRvIII Chimeric Antigen Receptor T Cells Demonstrate Favorable Safety Profile and Curative Responses in Orthotopic Glioblastoma.” Clinical & Translational Immunology, vol. 12, Jan. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b6811e689cb146ab4a513664347d1f95&authtype=sso&custid=ns315887.
APA
Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes‐Parry, Pete Smith, Melissa J Call, Ryan S Cross, & Misty R Jenkins. (2023). Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma. Clinical & Translational Immunology, 12.
Chicago
Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes‐Parry, Pete Smith, Melissa J Call, Ryan S Cross, and Misty R Jenkins. 2023. “Human EGFRvIII Chimeric Antigen Receptor T Cells Demonstrate Favorable Safety Profile and Curative Responses in Orthotopic Glioblastoma.” Clinical & Translational Immunology 12 (January). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b6811e689cb146ab4a513664347d1f95&authtype=sso&custid=ns315887.